Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria

Amino Acids

Volumn 42, Issue 5, 2012, Pages 1765-1772

  Kanzelmeyer, Nele ^a   Tsikas, Dimitrios ^a   Chobanyan Jürgens, Kristine ^a   Beckmann, Bibiana ^a   Vaske, Bernhard ^a   Illsinger, Sabine ^a   Das, Anibh M ^a   Lücke, Thomas ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

ADMA; Dimethylamine; Dimethylarginine dimethylaminohydrolase; Homocysteine; L Arginine; Nitric oxide

Indexed keywords

ARGININE; CREATININE; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE;

AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN RESTRICTION; SCHOOL CHILD; URINARY EXCRETION;

ADOLESCENT; AMIDOHYDROLASES; ARGININE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DIMETHYLAMINES; HOMOCYSTINURIA; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE; PHENYLKETONURIAS; RISK FACTORS; YOUNG ADULT;

EID: 84862773419     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0892-4     Document Type: Article

References (40)

1. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAlister R, Vallance P (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455-1459 (Pubitemid 36994536)
2. Austin RC, Lentz SR, Werstuck GH (2004) Role of hyperhomocystinuria in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11:56-64
3. Böger RH, Zoccali C (2003) ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl 4:23-28 (Pubitemid 38234491)
4. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95:2068-2074 (Pubitemid 27184275)
5. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwarzt BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561 (Pubitemid 28225719)
6. Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489-509 (Pubitemid 27101848)
7. Dayal S, Lentz SR (2005) ADMA and hyperhomocystinuria. Vasc Med 10(Suppl 1):27-33
8. Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR (2008) Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocystinuria. Am J Physiol Heart Circ Physiol 295:H816-H825
9. Hennermann JB, Roloff S, Gellermann J, Vollmer I, Mönch E (2005) Renal function in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis 28(Supp 1):18
10. Kielstein JT, Tsikas D, Fliser D (2006) Effects of asymmetric dimethylarginine (ADMA) infusion in humans. Eur J Clin Pharmacol 62:39-44
11. Kielstein A, Tsikas D, Galloway GP, Mendelson JE (2007) Asymmetric dimethylarginine (ADMA): A modulator of nociception in opiate tolerance and addiction? Nitric Oxide 17:55-59 (Pubitemid 47259726)
12. Korandji C, Zeller M, Guilland JC, Vergely C, Sicard P, Duvillard L, Gambert P, Moreau D, Cottin Y, Rochette L (2007) Asymmetric dimethylarginine (ADMA) and hyperhomocystinuria in patients with acute myocardial infarction. Clin Biochem 60:66-72 (Pubitemid 46019878)
13. Lücke T, Tsikas D, Kanzelmeyer N, Vaske B, Das AM (2006) Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in citrullinemia. Metabolism 55:1599-1603 (Pubitemid 44827125)
14. Lücke T, Kanzelmeyer N, Kemper MJ, Tsikas D, Das AM (2007) Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age. Clin Chem Lab Med 45:1525-1530 (Pubitemid 350036557)
15. Lücke T, Kanzelmeyer N, Chobanyan K, Tsikas D, Franke D, Kemper MJ, Ehrich JH, Das A (2008) Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transpl 23:734-740 (Pubitemid 351767646)
16. Mansoor MA, Kristensen O, Hervig T, Stakkestad JA, Berge T, Drablos PA, Rolfsen S, Wentzel-Larsen T (2005) Relationship between serum folate and plasma nitrate concentrations: possible clinical implications. Clin Chem 51:1266-1268 (Pubitemid 43079410)
17. Moens AL, Kass DA (2006) Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26:2439-2444 (Pubitemid 44607463)
18. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1-31 (Pubitemid 15138674)
19. Ozkor MA, Quyyumi AA (2008) Tetrahydrobiopterin. Curr Hypertens Rep 10:58-64 (Pubitemid 351255954)
20. Pham VV, Stichtenoth DO, Tsikas D (2009) Nitrite correlates with 3-nitrotyrosine but not with the F2-isoprostane 15(S)-8-iso- PGF2a in urine of rheumatic patients. Nitric Oxide 21:210-215
21. Schmidt TS, Alp NJ (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci 113:47-63 (Pubitemid 47066025)
22. Schroecksnadel K, Weiss G, Stanger O, Teerlink T, Fuchs D (2007) Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells. Scand J Immunol 65:525-529 (Pubitemid 46808852)
23. Schulpis KH, Karikas GA, Papakonstantinou E (2002) Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet. Acta Paediatr 91:905-909 (Pubitemid 34876223)
24. Sitta A, Barschak AG, Deon M, Terroso T, Pires R, Giugliani R, Dutra-Filho CS, Wajner M, Vargas CR (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287-296 (Pubitemid 46018234)
25. Spoelstra-de Man AM, Teerlink T, Brouwer CB, Rauwerda JA, Stehouwer CD, Smuöders YM (2006) No effect of B vitamins an ADMA levels in patients at increased cardiovascular risk. Clin Endocrinol 65:495-501
26. Tsikas D (2000) Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry. Anal Chem 72:4064-4072
27. Tsikas D (2003) Incorrect and inconsistent use of homocysteine's nomenclature: a potential source of misunderstandings. Eur J Clin Invest 33:1095-1096 (Pubitemid 38019144)
28. Tsikas D (2008) A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research. Anal Biochem 379:139-163
29. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Frölich JC (2000) Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 478:1-3 (Pubitemid 30462247)
30. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frölich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(Npentafluoropropionyl) derivative. J Chromatogr B 798:87-99 (Pubitemid 37421285)
31. Tsikas D, Wolf A, Frölich JC (2004) Simplified HPLC method for urinary and circulating creatinine. Clin Chem 50:201-203 (Pubitemid 38125719)
32. Tsikas D, Gutzki FM, Stichtenoth DO (2006) Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis. Eur J Clin Pharmacol 62:51-59
33. Tsikas D, Thum T, Becker T, Pham VV, Chobanyan K, Mitschke A, Beckmann B, Gutzki FM, Bauersachs J, Stichtenoth DO (2007) Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine. J Chromatogr B 851:229-239 (Pubitemid 46720136)
34. Tsikas D, Schwarz A, Stichtenoth DO (2010) Simultaneous measurement of [15N]nitrate and [15N]nitrite enrichment and concentration in urine by gas chromatography mass spectrometry as pentafluorobenzyl derivatives. Anal Chem 82:2585-2587
35. Verduyn I, Bosdet T, Selvage C, Sirrs S, O'Riley M (2005) Reduced HDL levels in adult patients with phenylketonuria (PKU). J Inherit Metab Dis 28(Suppl 1):56-64
36. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050 (Pubitemid 128753793)
37. Williams RA, Mamotte CDS, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31-41
38. Wolf C, Lorenzen JM, Stein S, Tsikas D, Störk S, Weidemann F, Ertl G, Anker SD, Bauersachs J, Thum T (2010) Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. Intern J Cardiol. doi: 10.1016/j.ijcard.2010.11.003
39. Wu G (2009) Amino acids: metabolism, functions, and nutrition. Amino Acids 37:1-17
40. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM, Satterfield MC, Smith SB, Spencer TE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153-168